Lv1
20 积分 2023-08-29 加入
Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
30天前
已完结
Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms
4个月前
已完结
The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes
4个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
6个月前
已完结
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
6个月前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
6个月前
已完结
The pathogenesis of melasma and implications for treatment
9个月前
已完结
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
10个月前
已完结
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
10个月前
已完结
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
10个月前
已完结
皖公网安备34019202002308
